MedTrace Logo

Intestinal Microbiome and Extremes of Atherosclerosis

NCT03398889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 316

Last updated 2018-01-16

No results posted yet for this study

Summary

Patients attending stroke prevention clinics and a premature atherosclerosis clinic at University Hospital in London, ON, Canada were recruited to the study. They completed a dietary questionnaire, provided stool samples and had blood drawn to measure plasma levels of metabolites produced by the intestinal bacteria.

Conditions

  • Gastrointestinal Microbiome, Atherosclerosis, Nutrients
  • Renal Function

Interventions

DIAGNOSTIC_TEST

Plasma levels of metabolites

plasma levels of metabolites

BEHAVIORAL

Dietary questionnaire

Harvard food frequency questionnaire

DIAGNOSTIC_TEST

Intestinal microbiome

amplification and sequencing of 16S rRNA gene variable regions in stool samples

Sponsors & Collaborators

  • London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-01
Primary Completion
2016-10-15
Completion
2016-10-15

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03398889 on ClinicalTrials.gov